Association of demographics, HCV co‐infection, HIV‐1 subtypes and genetic clustering with late HIV diagnosis: a retrospective analysis from the Japanese Drug Resistance HIV‐1 Surveillance Network
暂无分享,去创建一个
S. Matsushita | M. Koga | T. Matano | A. Hachiya | Y. Yokomaku | H. Gatanaga | Tsunefusa Hayashida | M. Horiba | M. Tateyama | Hideta Nakamura | T. Teshima | T. Kikuchi | Dai Watanabe | H. Mori | T. Shiino | S. Kato | M. Kondo | K. Sadamasu | Y. Yoshino | R. Minami | K. Yoshimura | H. Igari | T. Taniguchi | S. Uno | T. Fujii | M. Nishizawa | Asako Nakamura | H. Moro | K. Takada | S. Samukawa | H. Nakajima | Tamayo Watanabe | M. Nagashima | Toshihiro Ito | W. Sugiura | Shingo Kato | Machiko Otani | Machiko Otani | Teiichiro Shiino | Atsuko Hachiya | Hiroyuki Gatanaga | Rumi Minami | Masako Nishizawa | Shigeru Yoshida | Toshihiro Ito | Tsunefusa Hayashida | Michiko Koga | Mami Nagashima | Kenji Sadamasu | Makiko Kondo | Shunsuke Uno | Toshibumi Taniguchi | Hidetoshi Igari | Sei Samukawa | Hideaki Nakajima | Yusuke Yoshino | Masahide Horiba | Hiroshi Moro | Tamayo Watanabe | Mayumi Imahashi | Yoshiyuki Yokomaku | Haruyo Mori | Teruhisa Fujii | Kiyonori Takada | Asako Nakamura | Hideta Nakamura | Masao Tateyama | Shuzo Matsushita | Kazuhisa Yoshimura | Wataru Sugiura | Tetsuro Matano | Tadashi Kikuchi | Mayumi Imahashi | Shigeru Yoshida
[1] S. Oka. HIV testing in COVID-19 pandemic and beyond in Japan. , 2021, Global health & medicine.
[2] M. Fararouei,et al. Late diagnosis of HIV infection and its associated factors in Shiraz, Southern Iran: a retrospective study , 2021, AIDS care.
[3] R. Paredes,et al. Determinants of HIV-1 Late Presentation in Patients Followed in Europe , 2021, Pathogens.
[4] A. Kelleher,et al. Subtype‐specific differences in transmission cluster dynamics of HIV‐1 B and CRF01_AE in New South Wales, Australia , 2021, Journal of the International AIDS Society.
[5] Wei He,et al. Dynamics of HIV-1 Molecular Networks Reveal Effective Control of Large Transmission Clusters in an Area Affected by an Epidemic of Multiple HIV Subtypes , 2020, Frontiers in Microbiology.
[6] M. Horberg,et al. Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016 , 2020, JAMA network open.
[7] R. Guy,et al. Trends in late and advanced HIV diagnoses among migrants in Australia; implications for progress on Fast-Track targets , 2020, Medicine.
[8] Y. Liang,et al. HIV‐1 genotype is independently associated with immunodeficiency progression among Chinese men who have sex with men: an observational cohort study , 2019, HIV medicine.
[9] T. Kawahata,et al. Estimating HIV-1 incidence in Japan from the proportion of recent infections , 2019, Preventive medicine reports.
[10] T. Geijtenbeek,et al. Sexually transmitted hepatitis C virus infections: current trends, and recent advances in understanding the spread in men who have sex with men , 2019, Journal of the International AIDS Society.
[11] R. Hayes,et al. Impact of a universal testing and treatment intervention on HIV incidence in Zambia and South Africa: results of the HPTN 071 (PopART) community-randomized trial , 2019, The New England Journal of Medicine.
[12] N. Pantazis,et al. Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort , 2019, AIDS.
[13] Hiroshi Nishiura,et al. Estimating the incidence and diagnosed proportion of HIV infections in Japan: a statistical modeling study , 2019, PeerJ.
[14] V. Cooper,et al. Factors associated with testing for HIV in people aged ≥50 years: a qualitative study , 2018, BMC Public Health.
[15] H. Luma,et al. Late presentation to HIV/AIDS care at the Douala general hospital, Cameroon: its associated factors, and consequences , 2018, BMC Infectious Diseases.
[16] Steven Weaver,et al. HIV-TRACE (TRAnsmission Cluster Engine): a Tool for Large Scale Molecular Epidemiology of HIV-1 and Other Rapidly Evolving Pathogens. , 2018, Molecular biology and evolution.
[17] R. Hogg,et al. The Continuum of HIV Care in Rural Communities in the United States and Canada: What Is Known and Future Research Directions , 2017, Journal of acquired immune deficiency syndromes.
[18] Mahbubur Rahman,et al. The HIV care cascade: Japanese perspectives , 2017, PloS one.
[19] D. Fierer,et al. Shedding of Hepatitis C Virus Into the Rectum of HIV-infected Men Who Have Sex With Men , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] Ben Murrell,et al. Social and Genetic Networks of HIV-1 Transmission in New York City , 2017, PLoS pathogens.
[21] Art F. Y. Poon,et al. Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: an implementation case study , 2016, The lancet. HIV.
[22] J. Sterne,et al. Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] P. Phanuphak,et al. Late Presentation into Care of HIV Disease and Its Associated Factors in Asia: Results of TAHOD. , 2016, AIDS research and human retroviruses.
[24] P. Reiss,et al. Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996–2014: results from a national observational cohort , 2016, BMJ Open.
[25] Derek R. Smith,et al. HIV testing and attitudes among the working-age population of Japan: annual health checkups may offer an effective way forwards , 2015, Industrial health.
[26] S. Oka,et al. What Triggers a Diagnosis of HIV Infection in the Tokyo Metropolitan Area? Implications for Preventing the Spread of HIV Infection in Japan , 2015, PloS one.
[27] D. Fierer,et al. Acute HCV in HIV-Infected MSM: Modes of Acquisition, Liver Fibrosis, and Treatment , 2015, Current HIV/AIDS Reports.
[28] J. del Romero,et al. Effects of region of birth, educational level and age on late presentation among men who have sex with men newly diagnosed with HIV in a network of STI/HIV counselling and testing clinics in Spain. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[29] P. Harrigan,et al. The impact of clinical, demographic and risk factors on rates of HIV transmission: a population-based phylogenetic analysis in British Columbia, Canada. , 2015, The Journal of infectious diseases.
[30] R. Geskus,et al. Stabilizing Incidence of Hepatitis C Virus Infection Among Men Who Have Sex With Men in Amsterdam , 2014, Journal of acquired immune deficiency syndromes.
[31] R. Detels,et al. Baseline CD4 Cell Counts of Newly Diagnosed HIV Cases in China: 2006–2012 , 2014, PloS one.
[32] Anne M Johnson,et al. Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE) , 2013, PLoS medicine.
[33] D. Richman,et al. HIV-1 Clade B pol Evolution following Primary Infection , 2013, PloS one.
[34] Ming-Siang Huang,et al. Slow immunological progression in HIV-1 CRF07_BC-infected injecting drug users , 2013, Emerging Microbes & Infections.
[35] J. Willig,et al. Late Diagnosis, Delayed Presentation and Late Presentation in HIV: Proposed Definitions, Methodological Considerations and Health Implications , 2013, Antiviral therapy.
[36] Michael Rayment,et al. Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.
[37] H. Stellbrink,et al. Late presentation for HIV diagnosis and care in Germany , 2012, HIV medicine.
[38] S. Oka,et al. Trends in early and late diagnosis of HIV-1 infections in Tokyoites from 2002 to 2010. , 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[39] Louisa Degenhardt,et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews , 2011, The Lancet.
[40] Lei Wang,et al. Prevention of HIV-1 infection with early antiretroviral therapy. , 2011, The New England journal of medicine.
[41] H. Krentz,et al. Despite CD4 cell count rebound the higher initial costs of medical care for HIV-infected patients persist 5 years after presentation with CD4 cell counts less than 350 μl , 2010, AIDS.
[42] Richard D Moore,et al. Late presentation for human immunodeficiency virus care in the United States and Canada. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[43] A. Ogawa,et al. [The role of oncology nurse in palliative care team--activities of oncology certified nurse specialist in palliative care team at National Hospital Organization Osaka National Hospital]. , 2007, Gan to kagaku ryoho. Cancer & chemotherapy.
[44] G. Marks,et al. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA , 2006, AIDS.
[45] Ming Zhang,et al. A jumping profile Hidden Markov Model and applications to recombination sites in HIV and HCV genomes , 2006, BMC Bioinformatics.
[46] A. Mocroft,et al. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. , 2005, The Journal of infectious diseases.
[47] M. Graf,et al. Characterization of a Virtually Full-Length Human Immunodeficiency Virus Type 1 Genome of a Prevalent Intersubtype (C/B′) Recombinant Strain in China , 2000, Journal of Virology.